Denali Therapeutics Inc. (DNLI) Net income 2016–2025
Denali Therapeutics Inc. (DNLI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$512.5MFY2025 · since FY2016: -$86.7M → -$512.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$512.5M | -21.2% |
| FY2024 | -$422.8M | -191.1% |
| FY2023 | -$145.2M | +55.5% |
| FY2022 | -$326.0M | -12.2% |
| FY2021 | -$290.6M | -508.5% |
| FY2020 | $71.1M | +136.0% |
| FY2019 | -$197.6M | -445.3% |
| FY2018 | -$36.2M | +58.9% |
| FY2017 | -$88.2M | -1.8% |
| FY2016 | -$86.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice